Pharmacoeconomic Analysis of the use of Hepatoprotectors in Management of Drug-Associated Liver Injury Due to Hodgkin's Lymphoma Chemotherapy
Morikov, D.D.; Morikova, E.G.; Dvornichenko, V.V.
Antibiotiki i Khimioterapiia 60(7-8): 23-26
2015
ISSN/ISBN: 0235-2990 PMID: 26863739 Document Number: 679939
The data on the pharmacoeconomic research of the use of Remaxol in treatment of drug-associated liver injury due to the chemotherapy in cancer patients are presented. The costs-efficiency method was applied to two groups of the patients with drug-associated liver injury treated according to different schemes. The research showed economical benefits of the Remaxol use.
Document emailed within 1 workday
Related Documents
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180Saito, Y.; Kikuchi, Y.; Hayasaka, K.; Amoh, K.; Fujita, M.; Uekita, Y.; Nishino, S. 1989: Effective evaluation of combination chemotherapy in stage I-Ii of non-Hodgkin's lymphoma--a comparison of treatment with multivariate analysis Gan no Rinsho. Japan Journal of Cancer Clinics 35(7): 804-810
Fedder, G.; Somers, R. 1982: Non-Hodgkin lymphoma following radio- and chemotherapy of Hodgkin's disease Nederlands Tijdschrift Voor Geneeskunde 126(38): 1730-1733
Bucerius, J.; Herkel, C.; Joe, A.Y.; Altehoefer, C.; Finke, J.; Moser, E.; Reinhardt, M.J. 2006: (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies Nuklearmedizin. Nuclear medicine 45(3): 105-10; quiz N25-6
Lambert, J.; Wijermans, P.W.; Dekker, G.A.; Ossenkoppele, G.J. 1991: Chemotherapy in non-Hodgkin's lymphoma during pregnancy Netherlands Journal of Medicine 38(1-2): 80-85
Yazici, H.; Saip, P.; Inanç, S.; Onat, H.; Dalay, N. 1998: Investigation of the molecular changes during chemotherapy in non-Hodgkin's lymphoma Research Communications in Molecular Pathology and Pharmacology 100(3): 301-311
Horikoshi, N.; Inagaki, J.; Ogawa, M. 1983: Chemotherapy for advanced non-Hodgkin's lymphoma with CVP therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(8): 1885-1891
Mitarnun, W.; Pradutkanchana, J.; Takao, S.; Saechan, V.; Suwiwat, S.; Ishida, T. 2002: Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis Journal of the Medical Association of Thailand 85(5): 552-559
Tanaka, K.; Kaetsu, T.; Suzuki, S.; Kusano, M.; Yajima, S.; Sakamaki, H.; Ikeda, S.; Ikegami, N.; Murayama, J-Ichiro. 2003: Pharmacoeconomic study of chemotherapy for gastric cancer: analysis of medical costs for oral fluoropyrimidine TS-1 and conventional i.v therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(1): 73-80
Jain, S.; Moger, V.; Kumari, S.; Varma, S. 2001: Ifosfamide induced encephalopathy following chemotherapy of Non-Hodgkin's Lymphoma Neurology India 49(4): 416
Fielding, A.K.; Pearce, R.M.; Goldstone, A.H. 1995: Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma New England Journal of Medicine 333(11): 729; Author Reply 730
Fujiu, K.; Sakuma, H.; Shio, Y.; Suzuki, H.; Mori, M. 2008: A case of non-Hodgkin's lymphoma after chemotherapy for cancer of unknown origin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(11): 1907-1909
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Moore, D.T.; Taslimi, M.M. 1991: Multi-agent chemotherapy in a case of non-Hodgkin's lymphoma in second trimester of pregnancy Journal of the Tennessee Medical Association 84(9): 435-436
Picozzi, V.J.; Pohlman, B.L.; Morrison, V.A.; Lawless, G.D.; Lee, M.W.; Kerr, R.O.; Ford, J.M.; Delgado, D.J.; Fridman, M.; Carter, W.B. 2001: Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma Oncology 15(10): 1296-1306; Discussion: 1310-1311, 1314
Carpentieri, U.; Lockhart, L.H. 1978: Ataxia and athetosis as side effects of chemotherapy with vincristine in non-Hodgkin's lymphoma Cancer Treatment Reports 62(4): 561-562
Jurczak, W.; Nowak, W.; Wójcik, M.; Skotnicki, A. 1999: Non Hodgkin's lymphoma--treatment of choice and the role of high dose chemotherapy Przeglad lekarski 56 Suppl. 1: 80-89
Landgren, O.; Algernon, C.; Axdorph, U.; Nilsson, B.; Wedelin, C.; Porwit-MacDonald, A.; Grimfors, G.; Björkholm, M. 2003: Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis Haematologica 88(4): 438-444
Abdou, A.G.; Kandil, M.; Eldien, M.S.; Abdallah, R. 2016: Splenic histiocyte-rich pseudotumor following chemotherapy for non Hodgkin diffuse large B cell lymphoma Pathologica 108(3): 140-143
Somoza, N.; Morgenfeld, M.C.; Magnasco, J.; Pavlovsky, S.; Cavagnaro, F.J.; Saslavsky, J.; de Maria, H.; Macchi, A.; Suárez, A. 1978: Comparative study of two drug combination in non-Hodgkin's lymphoma Sangre 23(4): 418-425